Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2020-A02403-36 | Other Identifier | ANSM |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Overweight or obese patients are particularly exposed to severe forms of COVID-19. Few data suggest that adipose tissue infected with SARS-CoV-2 could be involved in the onset of the cytokine storm seen in severe forms of COVID-19. The aim of this study is to determine the pathogenesis of SARS-CoV-2-infection of adipose tissue. In particular the investigators will study how this virus enters the adipocyte and how it modulates metabolism and inflammation in the adipose tissue. From these data, the investigators hope to determine at the adipose tissue level, original therapeutic targets to modulate the effects of SARS-CoV-2 at the systemic level.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Obese or overweight patients |
| ||
| Patients without overweight |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Adipose tissue | Other | Adipose tissue sampling |
|
| Measure | Description | Time Frame |
|---|---|---|
| Comparison of the expression of ACE2 and TMPRSS2 in the subcutaneous and visceral adipose tissue of obese patients. Determination of cells expressing ACE2 and TMPRSS2 in whole human adipose tissue. | Analysis of the expression of mRNA and ACE2 and TMPRSS2 proteins in the subcutaneous and visceral adipose tissue of normal weight and obese patients | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Demonstration of entry and replication of SARS-CoV-2 in human adipose tissue | Infection of human adipocytes in lean and obese subjects by SARS-CoV-2 | 12 months |
| Consequences of infection with SARS-CoV-2 on the metabolism and inflammatory state of adipose tissue. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Obese and thin patients operated on for abdominal vascular surgery.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Olivier BOURRON, Dr | Contact | 0142178118 | olivier.bourron@aphp.fr |
| Name | Affiliation | Role |
|---|---|---|
| Olivier BOURRON, Dr | Hôpital Pitié Salpêtrière - Assistance Publique Hôpitaux de Paris | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Hôpital de la Pitié Salpêtrière | Paris | 75013 | France |
Not provided
| ID | Term |
|---|---|
| D000086382 | COVID-19 |
| ID | Term |
|---|---|
| D011024 | Pneumonia, Viral |
| D011014 | Pneumonia |
| D012141 | Respiratory Tract Infections |
| D007239 | Infections |
Not provided
Not provided
Not provided
Not provided
Not provided
Assessment of the expression and secretion of inflammatory cytokines (TNF-α, IL-1 , IL-4 , IL-6 , IL-7 , IL-10 , IL-12 , IL-13 , IL-18 ¸ IL-23, INF-α, INF-β) after infection with SARS-CoV-2 of adipose tissue / adipocytes of thin and obese subjects. Evaluation of SARS-CoV-2 infection on the lipolysis of adipose tissue / adipocytes in thin and obese subjects. |
| 12 months |
| Consequences of infection with SARS-CoV-2 on the metabolism and inflammatory state of adipose tissue. | Evaluation of SARS-CoV-2 infection on the lipolysis of adipose tissue / adipocytes in thin and obese subjects. | 12 months |
| Effect of SARS-CoV-2 infection of adipose tissue / adipocytes from thin and obese subjects on endoplasmic reticulum (ER) homeostasis. | Study whether infection with SARS-CoV-2 activates the RE stress pathways in adipose tissue | 12 months |
| Target endoplasmic reticulum stress to reduce spread of SARS-CoV-2 from adipose tissue | Use of RE stress inhibitors on adipocytes infected with SARS-CoV-2 and assess their effect on the maturation of the virus in infected cells. | 12 months |
| D014777 |
| Virus Diseases |
| D018352 | Coronavirus Infections |
| D003333 | Coronaviridae Infections |
| D030341 | Nidovirales Infections |
| D012327 | RNA Virus Infections |
| D008171 | Lung Diseases |
| D012140 | Respiratory Tract Diseases |